Raptiva for psoriasis

December 2003

Patients will soon be able to use Raptiva for psoriasis.

Raptiva (efalizumab) is a new biotech drug. It's an antibody that blocks T-cells that play a role in psoriasis.

It's similar to the psoriasis drug, Amevive (alefacept)... but each drug blocks different T-cell receptors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

now recommend AGAINST keeping ipecac syrup on hand for accidental poisonings
Cardiology Reports in the lay press are suggesting that it's dangerous for patients to stop low-dose aspirin
Cardiology valsartan (Diovan) improves survival after a heart attack
Gastroenterology confusion about the new OTC version of Prilosec
Cholesterol food products marketed as "heart healthy"
Cholesterol Which statins should to be taken in the evening?
Neurology & Pain whether opiates cause hearing loss
Antidepressants New alternatives to Paxil are hitting the market
Antidepressants More stroke patients are now getting an antidepressant
Asthma Is it necessary to taper a short course of oral corticosteroids?
More bipolar patients will be getting lithium
Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic
Psoriasis Raptiva for psoriasis
Women's Health new Rx estrogen cream, Estrasorb
Medication Errors eliminate dangerous abbreviations from prescriptions
Anticoagulants new oral anticoagulant called Exanta (ximelagatran, zye-mel-a-GAT-ran)
Practice Cialis (tadalafil), the new long-acting drug for erectile dysfunction